Marfan Syndrome: Genetics, Pathophysiology, and Inheritance
Marfan syndrome is an autosomal dominant connective tissue disorder caused by pathogenic variants in FBN1 (fibrillin-1) on chromosome 15q21.1.
Molecular Pathogenesis
- Fibrillin-1 is a major structural component of microfibrils, which scaffold elastin and regulate TGF-β bioavailability.
- Mutant fibrillin-1 → defective microfibrils → excessive TGF-β signaling → tissue remodeling, elastin fragmentation, impaired structural integrity.
Inheritance
- Autosomal Dominant: One mutant allele suffices. 50% transmission risk per pregnancy.
- De Novo Mutations: ~25% of cases; neither parent carries the variant.
- Variable Expressivity: Same mutation → wide phenotypic range (mild to severe) within families.
Other Genes
- TGFBR1/2 (Loeys-Dietz syndrome) – overlapping features (arterial aneurysm, hypertelorism, bifid uvula).
- SMAD3, TGFB2, FBN2 – related aortopathies.
Diagnostic Criteria (Ghent Nosology)
- Ectopia lentis + aortic root dilation (Z≥2) + FBN1 mutation = definitive.
- Systemic score (skeletal, ocular, cardiovascular, pulmonary, skin, dura) guides diagnosis when genetics unavailable.
Multidisciplinary care (cardiology, ophthalmology, orthopedics, genetics) enables normal lifespan with surveillance and prophylactic aortic root replacement.
Genetic Disorders - Related Articles
- Stickler Syndrome: Genetic Basis, Prevalence, and Ethnicity
- Grand Mal Epilepsy and Fertility: Understanding the Impact
- Brachydactyly (Short Fingers): Genetic Causes, Syndromes, and Prenatal Factors
- Carrier Status Explained: Genetic Inheritance and Recessive Disorders
- Bipolar Disorder: Understanding Genetics & Inheritance
- Albinism Inheritance: Autosomal Recessive Pattern Explained
- Down Syndrome: Future Trends in Diagnosis, Treatment, and Support
